The perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor

Brain Tumor Pathology

Volumn 32, Issue 1, 2015, Pages 41-48

  Sugita, Yasuo ^a   Terasaki, Mizuhiko ^a   Nakashima, Shinji ^a   Ohshima, Koichi ^a   Morioka, Motohiro ^a   Abe, Hideyuki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CXCL12; CXCL13; Endothelin B receptor; Immune escape; Primary central nervous system lymphoma

Indexed keywords

CHEMOKINE; CXCL13 CHEMOKINE; ENDOGLIN; ENDOTHELIN B RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE EVASION; LYMPHOMA CELL; MALE; MIDDLE AGED; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; UPREGULATION; VERY ELDERLY; CENTRAL NERVOUS SYSTEM TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOMA; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMOKINE CXCL12; CHEMOKINE CXCL13; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; RECEPTOR, ENDOTHELIN B; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84922105871     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-014-0206-0     Document Type: Article

References (31)

1. Deckert M, Paulus W (2007) Malignant lymphomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Pathology and Genetics of Tumours of the Nervous System. International Agency for Research on Cancer Press, Lyon, pp 188–192
2. Sugita Y, Tokunaga O, Nakashima A, Shigemori M (2004) SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts. Pathol Int 54:659–666
3. Kucia M, Jankowski K, Reca R et al (2004) CXCR4-SDF1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245
4. Teicher BA, Fricker SP (2007) CXCL12(SDF1)/CXCR4 pathway in cancer. Clin Cancer Res 16:2927–2931
5. Lazarini F, Tham TN, Casanova P et al (2003) Role of the alpha-chemokine stromal cell-derived factor (SDF1) in the developing and mature central nervous system. Glia 42:139–148
6. Barbieri F, Bajetto A, Florio T et al (2010) Network in the development and progression of ovarian cancer: a potential novel pharmacological target. J Oncol 61:4961–4965
7. Singh S, Singh UP, Grizzle WE et al (2004) CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84:1666–1676
8. Jiang Y, Wu X-H, Shi B et al (2006) Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103:226–233
9. Yasumoto K, Koizumi K, Kawashima A et al (2006) Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66:2181–2187
10. Folkins C, Shaked Y, Man S et al (2009) Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 69:7243–7251
11. Smith JR, Braziel RM, Paoletti S et al (2003) Expression of B-cell-attracting chemokine 1(CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 101:815–821
12. Brunn A, Montesinos-Rongen M, Strack A et al (2007) Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma. Acta Neuropathathol 114:271–276
13. Smith JR, Falkenhagen KM, Coupland SE et al (2007) Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol 127:633–641
14. Jahnke K, Coupland SE, Na IK et al (2005) Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma. Blood 106:384–385
15. Fischer L, Korfel A, Pfeiffer S et al (2007) CXCL13 and CXCL12 in central nervous system lymphoma patients. Clin Cancer Res 15:5968–5973
16. Venetz D, Ponzoni M, Schiraldi M et al (2010) Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int J Cancer Res 127:2300–2312
17. Yanagisawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
18. Inoue A, Yanagisawa M, Kimura S et al (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad of Sci USA 86:2863–2867
19. Ahmed SI, Thompson J, Coulson JM, Woll PJ (2000) Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol 22:422–431
20. Rosano L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A (2001) Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 61:8340–8346
21. Kusuhara M, Yamaguchi K, Nagasaki K et al (1990) Production of endothelin in human cancer cell lines. Cancer Res 50:3257–3261
22. Nelson JB, Chan-Tack K, Hedican SP et al (1996) Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56:663–668
23. Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G (2009) Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res 15:4521–4528
24. Paolillo M, Barbieri A, Zanassi P, Schinelli S (2006) Expression of endothelins and their receptors in glioblastoma cell lines. J Neurooncol 79:1–7
25. Anguelova E, Beuvon F, Leonard N et al (2005) Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas. Brain Res Mol Brain Res 137:77–88
26. Buckanovich RJ, Facciabene A, Kim S et al (2008) Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 14:28–36
27. Sugita Y, Takase Y, Mori D, Tokunaga O, Nakashima A, Shigemori M (2007) Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival. J Neurooncol 82:249–256
28. Kiyasu J, Aoki R, Tanaka PY et al (2012) FOXP3+ regulatory and TIA-1+ cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma. Pathol In 62:77–83
29. Komatani H, Sugita Y, Arakawa F et al. (2009) Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol 34:665–672
30. Ponzoni M, Berger F, Chassagne-Clement C et al (2007) Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol 138:316–323
31. Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G (2009) Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res 15:4521–4528